Ty Lin

Ty Lin has a robust background in the pharmaceutical industry and military leadership. As a Director at Pfizer from June 2018 to April 2021, Ty Lin held key roles in Novel Anti-Infectives Commercial Development and Rare Disease Portfolio & Decision Analysis, as well as serving as a Senior Manager in Portfolio & Decision Analysis. Prior military experience includes serving as an Infantry Officer in the United States Army from May 2009 to July 2014, with responsibilities as a Platoon Leader and Company Executive Officer. Academic qualifications include a Master of Business Administration (M.B.A.) from Harvard Business School, attained between January 2014 and January 2016, and a Bachelor's Degree in Biology/Biological Sciences from the United States Military Academy at West Point, completed in January 2009, with notable involvement in various academic and extracurricular activities.